logo

Biocryst Pharmaceuticals Inc (BCRX)



Trade BCRX now with
  Date
  Headline
12/22/2020 7:08:23 AM Amended: BioCryst Expects NIAID To Discontinue Pursuit Of A COVID-19 Indication For Galidesivir
12/21/2020 7:22:16 AM BioCryst Announces Positive Phase 1 Results With BCX9250 For Treatment Of Fibrodysplasia Ossificans Progressiva
12/16/2020 7:12:03 AM BioCryst Says ORLADEYO Is Now Available For Shipment To Patients With A Prescription In US
12/3/2020 8:52:31 PM BioCryst FDA Oks ORLADEYO, Oral, Once-daily Therapy To Prevent Attacks In Hereditary Angioedema Patients
11/13/2020 7:14:32 AM BioCryst Presents New Clinical Data On Berotralstat In APeX-2 Trial
8/31/2020 7:12:18 AM BioCryst Pharma: FDA Grants Orphan Drug Designation For BCX9930 For Paroxysmal Nocturnal Hemoglobinuria